XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Net product sales $ 169,061 $ 141,517 $ 448,998 $ 378,589
Cost of goods sold 19,467 13,279 46,382 38,107
Gross profit 149,594 128,238 402,616 340,482
Operating expenses:        
Research and development 23,415 26,160 112,102 79,172
Selling, general, and administrative 90,036 75,106 266,406 236,711
Restructuring charges 0 3,143 0 9,188
Loss on impairment of assets 0 0 1,702 0
Depreciation and amortization 1,874 2,170 5,563 6,506
Total operating expenses 115,325 106,579 385,773 331,577
Income from operations 34,269 21,659 16,843 8,905
Other expense:        
Interest income 829 1,081 2,484 3,991
Interest expense (11,711) (12,692) (34,731) (37,640)
Other income (expense) 10,887 (3,263) 12,452 (11,946)
Income (loss) before income tax 34,274 6,785 (2,952) (36,690)
Income tax expense (16,968) (13,514) (25,848) (34,155)
Net income (loss) attributable to common stockholders $ 17,306 $ (6,729) $ (28,800) $ (70,845)
Net income (loss) attributable to common stockholders per common share — basic (in dollars per share) $ 0.06 $ (0.02) $ (0.09) $ (0.23)
Net income (loss) attributable to common stockholders per common share — diluted (in dollars per share) $ 0.06 $ (0.02) $ (0.09) $ (0.23)
Weighted average common shares outstanding - basic (in shares) 308,468,423 304,690,596 308,139,134 303,792,479
Weighted average common shares outstanding - diluted (in shares) 310,433,494 304,690,596 308,139,134 303,792,479